Target intelligence / Profile preview

Cell-surface anionic components

Molecular classification
Glycosaminoglycan, Proteoglycan, Phospholipid, Sialic acid
01

Overview

Cell-surface anionic components refer to a heterogeneous group of negatively charged molecules located on the plasma membrane of host cells and pathogens. These components primarily include glycosaminoglycans (GAGs) such as heparan sulfate proteoglycans (HSPGs), sialic acids, and anionic phospholipids like phosphatidylserine (Campione et al., 2021; Valenti & Antonini, 2005). In the context of pharmacology, these molecules serve as critical attachment factors for various viruses, including SARS-CoV-2, HIV, and HCV, as well as numerous bacterial species, facilitating their initial docking and subsequent entry into host cells (Hu et al., 2021). Therapeutic strategies targeting these components often involve cationic proteins or peptides, such as lactoferrin and antimicrobial peptides (AMPs), which bind to the anionic sites through electrostatic interactions to competitively inhibit pathogen adhesion or disrupt membrane integrity (Berlutti et al., 2011). Additionally, the exposure of certain anionic components like phosphatidylserine on the outer leaflet of cancer cells—a phenomenon typically absent in healthy cells—provides a selective target for anticancer therapies and imaging agents. This broad target class is essential for maintaining membrane potential and mediating cell-cell and cell-matrix interactions, though its non-specific nature presents challenges in achieving high therapeutic selectivity.

Other names
Anionic cell surface componentsAnionic surface moleculesNegatively charged cell surface componentsAnionic membrane componentsCell surface glycosaminoglycans
02

Mechanism of action

Competitive inhibition of pathogen attachment; membrane disruption; opsonization of apoptotic or malignant cells

03

Biological functions

Cell adhesionPathogen attachmentSignal transductionMembrane integrityIon homeostasis
04

Disease associations

InfectionCancerInflammationCoagulopathy
05

Safety considerations

NephrotoxicityNeurotoxicityHemolysisNon-specific binding to healthy tissues
06

Interacting drugs

Lactoferrin

6 more in the full profile.

07

Biomarkers

Phosphatidylserine exposureHeparan sulfate expressionAnnexin V binding

Beyond the preview

Go deeper on Cell-surface anionic components.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell-surface anionic components.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call